World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Biotech Firms, Billions at Risk, Lobby States to Limit Generics
Keywords:
Biotech companies and efforts to limit generics
01/28/2013
Higher pricing would reduce savings from health care reforms.
Grouped Articles
Potential for Deals Drives a Big Surge in the Biotech Sector
New York Times 07/11/2013
Biotech Stocks' Rout Perplexes Analysts
Wall Street Journal 04/11/2014
Biotech Firms, Billions at Risk, Lobby States to Limit Generics
New York Times 01/28/2013
Lobbying by the U.S. pharmaceutical and healthcare industry.
06/25/2008
Grouped Articles
Obama's Health Expert Gets Political
Wall Street Journal 07/24/2009
Wall Street Journal 06/25/2008
Drug Industry Adapts to Democrats' Mounting Clout
Wall Street Journal 10/24/2008
William Daley Brings Management Experience as Chief of Staff
New York Times 01/06/2011
India and America, Two Peas in a Pod
New York Times 11/08/2011
White House visitor logs show lobbying going strong - The Washington Post
Washington Post 05/21/2012
Pricing of healthcare services and pharmaceuticals as the biggest problem in funding healthcare in the U.S.
01/31/2008
The cost of most healthcare services are double or higher in the U.S. than in Canada, Germany, France and Japan. By not bringing prices in line with the price in other major developed countries, the U.S. is effectively defunding infrastructure, R&D, education and other important means of improving competitiveness say experts. The methods of setting price present in these countries are notably absent in the U.S. The Obama healthcare bill and before that the Bush Medicare Prescription Drug Benefit simply leave this problem unaddressed.
Grouped Articles
Cuts Would Only Shift Health-Care Costs
Wall Street Journal 07/13/2011
Bayonne Medical Center Has Highest U.S. Billing Rates
New York Times 05/16/2013
The Soaring Cost of a Simple Breath
New York Times 10/12/2013
New York Times 12/21/2013
Economy Led to Cuts in Use of Health Care, Study Says
New York Times 08/16/2010
Washington Post 09/22/2015
Pharmaceutical company and industry lobbying in the U.S. Congress
06/25/2008
The influence on legislation and federal regulation that the pharmaceutical companies and industry associations are seeking, with $168 million spent on lobbying in 2006. As a result pricing of pharmaceutical products and healthcare services is the major unsolved problem in the U.S.
Grouped Articles
Wall Street Journal 06/25/2008
Health-Care Firms Have Supported Lawmakers Debating Reform
Washington Post 07/21/2009
Dana Milbank - Washington Sketch: GOP's Steele Couldn't Have Said It Better Himself
Washington Post 07/21/2009
Obama's Health Expert Gets Political
Wall Street Journal 07/24/2009
New York Times 08/02/2009
As Congress Goes on Break, Health Lobbying Heats Up
Wall Street Journal 08/05/2009
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us
